source
- STAT+: Skylark Bio kicks off new gene therapy trial for deafnessBiotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.STAT · 7h ago↗ source
- AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashesAbCellera Biologics’ reduction in hot flashes sets it apart from currently commercial oral drugs, including Astellas’ Veozah and Bayer’s Lynkuet, according to BMO Capital Markets.BioSpace · 8h ago↗ source
- Vaderis fuels up with $152M series B to test rare vascular disease in Phase 3Vaderis is hoping that engasertib will become the first approved medicine for hereditary hemorrhagic telangiectasia, a rare condition that can cause spontaneous bleeding.